Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Conclusions and clinical perspectives

Date

07 Oct 2016

Session

Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Presenters

Rolf A. Stahel

Authors

R.A. Stahel

Author affiliations

Clinik And Policlinic Of Oncology, Universitätsspital Zürich, 8091 - Zürich/CH

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

07 Oct 2016

Introduction

Presenter: Peter Schirmacher

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Slides

Webcast

07 Oct 2016

PDL 1 immunohistochemistry laboratory validation

Presenter: Mogens Vyberg

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Slides

Webcast

07 Oct 2016

PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours

Presenter: Solange Peters

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Slides

Webcast

07 Oct 2016

Beyond immunohistochemistry

Presenter: Ian Cree

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Slides

Webcast